AMERICAN JOURNAL OF HEMATOLOGY

Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

White matter has impaired resting oxygen delivery in sickle cell patients

Drug‐induced thrombocytopenia: 2019 Update of clinical and laboratory data

Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma

Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B‐cell malignancies: Results of a phase I study

Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia

Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial

Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation

Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis

Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma

Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study

Eligibility for CAR T‐cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL

Shortening the ex vivo culture of CD19‐specific CAR T‐cells retains potent efficacy against acute lymphoblastic leukemia without CAR T‐cell‐related encephalopathy syndrome or severe cytokine release syndrome

HemoTypeSC Demonstrates >99% Field Accuracy in a Sickle Cell Disease Screening Initiative in Children of Southeastern Uganda

Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease

Identifying leukemia‐associated immunophenotype‐based individualized minimal residual disease in acute myeloid leukemia and its prognostic significance

“Maximum tolerated dose” vs “fixed low‐dose” hydroxyurea for treatment of adults with sickle cell anemia

Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag

Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series

Third trimester and early postpartum period of pregnancy have the greatest risk for ACS in women with SCD

Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers

Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management

The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly‐annotated patients with primary myelofibrosis

The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia

Clinical and economic burden of regularly transfused adult patients with β‐thalassemia in the United States: A retrospective cohort study using payer claims

A prognostic index for nasal‐type early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study

Purpura fulminans from reduced protein S following cytomegalovirus and varicella infection

Haploidentical transplantation in high‐risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)

Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation

A confusing “white cell count”: Circulating micromegakaryocytes in post‐thrombocythemia myelofibrosis

Clinical outcomes with unfractionated heparin monitored by anti‐factor Xa vs. activated partial Thromboplastin time

Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it

Unusual presentations of sitosterolemia limited to hematological abnormalities: A report of four cases presenting with stomatocytic anemia and thrombocytopenia with macrothrombocytes

Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study

A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Outcome and impact of post‐remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia

Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Safety of autologous stem cell transplantation in patients with known Human T‐cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients

Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G‐CSF or G‐CSF and plerixafor mobilized grafts

Effect of novel agents on the risk of early death of newly diagnosed symptomatic multiple myeloma patients: A single Centre retrospective analysis

Extramedullary leukemia behaving as solid cancer: clinical, histologic, and genetic clues to chemoresistance in organ sites

Calculator‐free point‐of‐care prognostication in myelodysplastic syndromes

Unexpected babesiosis with dramatic morphological features

Be ever cautious until the truth is proven

Impact of natural neuromedin‐B receptor variants on iron metabolism

Predicting serum ferritin levels in patients with iron overload treated with the film‐coated tablet of deferasirox during the ECLIPSE study